Senior Vice President, CMC Development & Project ManagementVarmX, Leiden, The NetherlandsLeiden, Zuid-Holland, Netherlands
OC 31.3 - Phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of VMX-C001 in healthy subjects
Monday, June 26, 202311:15 – 11:30 ET